• In this Aug. 6, 2015 file photo, Sarah Jessica Parker attends the Broadway opening night of "Hamilton" in New York. Parker said she is “disappointed, saddened and deeply concerned” by the price hike of the EpiPen. She has cut ties with the company that makes the emergency allergy treatment. (Photo by Charles Sykes/Invision/AP, File)

    Sarah Jessica Parker cuts ties with EpiPen after price hike

    NEW YORK (AP) — Saying she is “disappointed, saddened and deeply concerned” by the price hike of the EpiPen, actress Sarah Jessica Parker has cut ties with the company that makes the emergency allergy treatment.

  • This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Mylan, now in the crosshairs over severe price hikes for its EpiPen, said Thursday, Aug. 25, 2016, it will expand programs that lower out-of-pocket costs by as much as half. (AP Photo/Mark Zaleski, File)

    Mylan boosts EpiPen patient programs, doesn’t budge on price

    The maker of EpiPens offered patients more help to pay for its costly emergency allergy shots but didn’t budge Thursday on the $608 price.

  • In this Friday, July 8, 2016 photo, a pharmacist holds a package of EpiPens, an epinephrine autoinjector for the treatment of allergic reactions, in Sacramento, Calif. Price hikes for the emergency medicine have made its maker, Mylan, the latest target for patients and politicians infuriated by soaring drug prices. (AP Photo/Rich Pedroncelli)

    How EpiPen’s maker raised prices, and hackles, so much

    TRENTON, N.J. (AP) — Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and politicians infuriated by soaring drug prices.